<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00234130</url>
  </required_header>
  <id_info>
    <org_study_id>RUH IRB # LHU 0486</org_study_id>
    <nct_id>NCT00234130</nct_id>
  </id_info>
  <brief_title>The Effect of Nighttime Dialysis on the Inflammation of Kidney Failure</brief_title>
  <official_title>A Comparison of the Effects of Conventional and Nocturnal Hemodialysis on the Inflammatory Response of Chronic Renal Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rockefeller University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Rogosin Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rockefeller University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will determine whether a new form of home hemodialysis carried out at night during&#xD;
      sleep reduces blood levels of hormone-like substances called cytokines that may cause fatigue&#xD;
      and increase blood fats and sugar. Participants will stay twice in the Rockefeller Hospital&#xD;
      and receive a standard diet and blood testing. Training for nocturnal hemodialysis will be&#xD;
      provided at the nearby Manhattan Dialysis Center of The Rogosin Institute, affiliated with&#xD;
      The Rockefeller University.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients treated with conventional hemodialysis for at least 3 months and interested in&#xD;
      learning home nocturnal hemodialysis will be screened in the Rockefeller Outpatient Research&#xD;
      Center. If eligible, during the first 8 day hospital stay, participants will receive a&#xD;
      standard diet and dialysis treatment nearby at the Rogosin Institute Dialysis Center. During&#xD;
      the last 2 days, their blood will be frequently sampled for cytokines, fats and sugar.&#xD;
      Dialysate will also be sampled. They will have the same diet and tests repeated during a&#xD;
      second admission after either 4 months of conventional dialysis or 1 month training for&#xD;
      nocturnal dialysis followed by 3 months of home nocturnal dialysis (randomized 1:1). After&#xD;
      the second admission, patients treated with conventional dialysis will be discharged from the&#xD;
      study and trained in nocturnal hemodialysis. Off-site computer monitoring will be utilized&#xD;
      when patients dialyze themselves at home or during the admission in The Rockefeller&#xD;
      University Hospital.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The patient population was not enough to complete enrollment&#xD;
  </why_stopped>
  <start_date>July 2002</start_date>
  <completion_date type="Actual">May 2006</completion_date>
  <primary_completion_date type="Actual">May 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility study</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Feasibility study</measure>
  </secondary_outcome>
  <enrollment>20</enrollment>
  <condition>End-Stage Renal Disease</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>nocturnal vs conventional dialysis</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Men and women at least age 18 who receive hemodialysis three times a week for at least 3&#xD;
        months and meet the criteria for home instruction in nocturnal dialysis -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        No diabetes, any unstable clinical condition, chronic infection (including hepatitis, HIV),&#xD;
        endocrine disorders or serious digestive problems, lipid-lowering medication , LDL&#xD;
        cholesterol &lt;190 mg/dL and triglycerides less than 600 mg/dL, body mass index &lt;35, blood&#xD;
        pressure &lt;160/100, hemoglobin &gt;10.0, no cholesterol-lowering medicine, able to change from&#xD;
        Renagel (has lipid effects) to Phoslo for the duration of the study, cigarette smoking no&#xD;
        more than half a pack per day&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lisa C. Hudgins, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rockefeller University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rockefeller University Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.rucares.org/clinicalstudies/list.php</url>
    <description>Related Info</description>
  </link>
  <verification_date>June 2009</verification_date>
  <study_first_submitted>October 5, 2005</study_first_submitted>
  <study_first_submitted_qc>October 5, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2005</study_first_posted>
  <last_update_submitted>June 2, 2009</last_update_submitted>
  <last_update_submitted_qc>June 2, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2009</last_update_posted>
  <responsible_party>
    <name_title>Lisa Hudgins, MD</name_title>
    <organization>Rockefeller University</organization>
  </responsible_party>
  <keyword>Dialysis</keyword>
  <keyword>Cytokines</keyword>
  <keyword>Triglycerides</keyword>
  <keyword>Insulin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

